Preventable Vaccines Market - Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of 1,4,5,8 - Naphthalene Tetracarboxylic Acid in global, including the following market information:
Global 1,4,5,8 - Naphthalene Tetracarboxylic Acid Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global 1,4,5,8 - Naphthalene Tetracarboxylic Acid Market Sales, 2017-2022, 2023-2028, (MT)
Global top five 1,4,5,8 - Naphthalene Tetracarboxylic Acid companies in 2021 (%)
The global 1,4,5,8 - Naphthalene Tetracarboxylic Acid market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Above 98.5% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of 1,4,5,8 - Naphthalene Tetracarboxylic Acid include Binhai Xingrong Fine Chemical, Langfang Longtengyu Fine Chemicals and Shanghai Longsheng Chemical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the 1,4,5,8 - Naphthalene Tetracarboxylic Acid manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global 1,4,5,8 - Naphthalene Tetracarboxylic Acid Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global 1,4,5,8 - Naphthalene Tetracarboxylic Acid Market Segment Percentages, by Type, 2021 (%)
Global 1,4,5,8 - Naphthalene Tetracarboxylic Acid Market Segment Percentages, by Application, 2021 (%)
Global 1,4,5,8 - Naphthalene Tetracarboxylic Acid Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies 1,4,5,8 - Naphthalene Tetracarboxylic Acid revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies 1,4,5,8 - Naphthalene Tetracarboxylic Acid revenues share in global market, 2021 (%)
Key companies 1,4,5,8 - Naphthalene Tetracarboxylic Acid sales in global market, 2017-2022 (Estimated), (MT)
Key companies 1,4,5,8 - Naphthalene Tetracarboxylic Acid sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global 1,4,5,8 - Naphthalene Tetracarboxylic Acid Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global 1,4,5,8 - Naphthalene Tetracarboxylic Acid Market Sales, 2017-2022, 2023-2028, (MT)
Global top five 1,4,5,8 - Naphthalene Tetracarboxylic Acid companies in 2021 (%)
The global 1,4,5,8 - Naphthalene Tetracarboxylic Acid market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Above 98.5% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of 1,4,5,8 - Naphthalene Tetracarboxylic Acid include Binhai Xingrong Fine Chemical, Langfang Longtengyu Fine Chemicals and Shanghai Longsheng Chemical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the 1,4,5,8 - Naphthalene Tetracarboxylic Acid manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global 1,4,5,8 - Naphthalene Tetracarboxylic Acid Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global 1,4,5,8 - Naphthalene Tetracarboxylic Acid Market Segment Percentages, by Type, 2021 (%)
- Above 98.5%
- Above 95%
- Others
Global 1,4,5,8 - Naphthalene Tetracarboxylic Acid Market Segment Percentages, by Application, 2021 (%)
- Dye
- Others
Global 1,4,5,8 - Naphthalene Tetracarboxylic Acid Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies 1,4,5,8 - Naphthalene Tetracarboxylic Acid revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies 1,4,5,8 - Naphthalene Tetracarboxylic Acid revenues share in global market, 2021 (%)
Key companies 1,4,5,8 - Naphthalene Tetracarboxylic Acid sales in global market, 2017-2022 (Estimated), (MT)
Key companies 1,4,5,8 - Naphthalene Tetracarboxylic Acid sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Binhai Xingrong Fine Chemical
- Langfang Longtengyu Fine Chemicals
- Shanghai Longsheng Chemical
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Preventable Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Preventable Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL PREVENTABLE VACCINES OVERALL MARKET SIZE
2.1 Global Preventable Vaccines Market Size: 2021 VS 2028
2.2 Global Preventable Vaccines Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Preventable Vaccines Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Preventable Vaccines Players in Global Market
3.2 Top Global Preventable Vaccines Companies Ranked by Revenue
3.3 Global Preventable Vaccines Revenue by Companies
3.4 Global Preventable Vaccines Sales by Companies
3.5 Global Preventable Vaccines Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Preventable Vaccines Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Preventable Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Preventable Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Preventable Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Preventable Vaccines Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Preventable Vaccines Market Size Markets, 2021 & 2028
4.1.2 Adult Preventable Vaccines
4.1.3 Pediatric Preventable Vaccines
4.2 By Type - Global Preventable Vaccines Revenue & Forecasts
4.2.1 By Type - Global Preventable Vaccines Revenue, 2017-2022
4.2.2 By Type - Global Preventable Vaccines Revenue, 2023-2028
4.2.3 By Type - Global Preventable Vaccines Revenue Market Share, 2017-2028
4.3 By Type - Global Preventable Vaccines Sales & Forecasts
4.3.1 By Type - Global Preventable Vaccines Sales, 2017-2022
4.3.2 By Type - Global Preventable Vaccines Sales, 2023-2028
4.3.3 By Type - Global Preventable Vaccines Sales Market Share, 2017-2028
4.4 By Type - Global Preventable Vaccines Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Preventable Vaccines Market Size, 2021 & 2028
5.1.2 Bacterial Diseases
5.1.3 Virus Diseases
5.2 By Application - Global Preventable Vaccines Revenue & Forecasts
5.2.1 By Application - Global Preventable Vaccines Revenue, 2017-2022
5.2.2 By Application - Global Preventable Vaccines Revenue, 2023-2028
5.2.3 By Application - Global Preventable Vaccines Revenue Market Share, 2017-2028
5.3 By Application - Global Preventable Vaccines Sales & Forecasts
5.3.1 By Application - Global Preventable Vaccines Sales, 2017-2022
5.3.2 By Application - Global Preventable Vaccines Sales, 2023-2028
5.3.3 By Application - Global Preventable Vaccines Sales Market Share, 2017-2028
5.4 By Application - Global Preventable Vaccines Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Preventable Vaccines Market Size, 2021 & 2028
6.2 By Region - Global Preventable Vaccines Revenue & Forecasts
6.2.1 By Region - Global Preventable Vaccines Revenue, 2017-2022
6.2.2 By Region - Global Preventable Vaccines Revenue, 2023-2028
6.2.3 By Region - Global Preventable Vaccines Revenue Market Share, 2017-2028
6.3 By Region - Global Preventable Vaccines Sales & Forecasts
6.3.1 By Region - Global Preventable Vaccines Sales, 2017-2022
6.3.2 By Region - Global Preventable Vaccines Sales, 2023-2028
6.3.3 By Region - Global Preventable Vaccines Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Preventable Vaccines Revenue, 2017-2028
6.4.2 By Country - North America Preventable Vaccines Sales, 2017-2028
6.4.3 US Preventable Vaccines Market Size, 2017-2028
6.4.4 Canada Preventable Vaccines Market Size, 2017-2028
6.4.5 Mexico Preventable Vaccines Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Preventable Vaccines Revenue, 2017-2028
6.5.2 By Country - Europe Preventable Vaccines Sales, 2017-2028
6.5.3 Germany Preventable Vaccines Market Size, 2017-2028
6.5.4 France Preventable Vaccines Market Size, 2017-2028
6.5.5 U.K. Preventable Vaccines Market Size, 2017-2028
6.5.6 Italy Preventable Vaccines Market Size, 2017-2028
6.5.7 Russia Preventable Vaccines Market Size, 2017-2028
6.5.8 Nordic Countries Preventable Vaccines Market Size, 2017-2028
6.5.9 Benelux Preventable Vaccines Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Preventable Vaccines Revenue, 2017-2028
6.6.2 By Region - Asia Preventable Vaccines Sales, 2017-2028
6.6.3 China Preventable Vaccines Market Size, 2017-2028
6.6.4 Japan Preventable Vaccines Market Size, 2017-2028
6.6.5 South Korea Preventable Vaccines Market Size, 2017-2028
6.6.6 Southeast Asia Preventable Vaccines Market Size, 2017-2028
6.6.7 India Preventable Vaccines Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Preventable Vaccines Revenue, 2017-2028
6.7.2 By Country - South America Preventable Vaccines Sales, 2017-2028
6.7.3 Brazil Preventable Vaccines Market Size, 2017-2028
6.7.4 Argentina Preventable Vaccines Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Preventable Vaccines Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Preventable Vaccines Sales, 2017-2028
6.8.3 Turkey Preventable Vaccines Market Size, 2017-2028
6.8.4 Israel Preventable Vaccines Market Size, 2017-2028
6.8.5 Saudi Arabia Preventable Vaccines Market Size, 2017-2028
6.8.6 UAE Preventable Vaccines Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Corporate Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Preventable Vaccines Major Product Offerings
7.1.4 GlaxoSmithKline Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.1.5 GlaxoSmithKline Key News
7.2 Merck
7.2.1 Merck Corporate Summary
7.2.2 Merck Business Overview
7.2.3 Merck Preventable Vaccines Major Product Offerings
7.2.4 Merck Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.2.5 Merck Key News
7.3 Novartis
7.3.1 Novartis Corporate Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Preventable Vaccines Major Product Offerings
7.3.4 Novartis Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.3.5 Novartis Key News
7.4 Pfizer
7.4.1 Pfizer Corporate Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Preventable Vaccines Major Product Offerings
7.4.4 Pfizer Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.4.5 Pfizer Key News
7.5 Sanofi
7.5.1 Sanofi Corporate Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Preventable Vaccines Major Product Offerings
7.5.4 Sanofi Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.5.5 Sanofi Key News
7.6 Takeda Pharmaceutical
7.6.1 Takeda Pharmaceutical Corporate Summary
7.6.2 Takeda Pharmaceutical Business Overview
7.6.3 Takeda Pharmaceutical Preventable Vaccines Major Product Offerings
7.6.4 Takeda Pharmaceutical Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.6.5 Takeda Pharmaceutical Key News
7.7 Abbott
7.7.1 Abbott Corporate Summary
7.7.2 Abbott Business Overview
7.7.3 Abbott Preventable Vaccines Major Product Offerings
7.7.4 Abbott Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.7.5 Abbott Key News
7.8 Roche
7.8.1 Roche Corporate Summary
7.8.2 Roche Business Overview
7.8.3 Roche Preventable Vaccines Major Product Offerings
7.8.4 Roche Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.8.5 Roche Key News
7.9 AstraZeneca
7.9.1 AstraZeneca Corporate Summary
7.9.2 AstraZeneca Business Overview
7.9.3 AstraZeneca Preventable Vaccines Major Product Offerings
7.9.4 AstraZeneca Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.9.5 AstraZeneca Key News
7.10 Mitsubishi Tanabe Pharma
7.10.1 Mitsubishi Tanabe Pharma Corporate Summary
7.10.2 Mitsubishi Tanabe Pharma Business Overview
7.10.3 Mitsubishi Tanabe Pharma Preventable Vaccines Major Product Offerings
7.10.4 Mitsubishi Tanabe Pharma Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.10.5 Mitsubishi Tanabe Pharma Key News
7.11 Lupin
7.11.1 Lupin Corporate Summary
7.11.2 Lupin Preventable Vaccines Business Overview
7.11.3 Lupin Preventable Vaccines Major Product Offerings
7.11.4 Lupin Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.11.5 Lupin Key News
7.12 Serum Institute of India
7.12.1 Serum Institute of India Corporate Summary
7.12.2 Serum Institute of India Preventable Vaccines Business Overview
7.12.3 Serum Institute of India Preventable Vaccines Major Product Offerings
7.12.4 Serum Institute of India Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.12.5 Serum Institute of India Key News
7.13 LG Life Sciences
7.13.1 LG Life Sciences Corporate Summary
7.13.2 LG Life Sciences Preventable Vaccines Business Overview
7.13.3 LG Life Sciences Preventable Vaccines Major Product Offerings
7.13.4 LG Life Sciences Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.13.5 LG Life Sciences Key News
7.14 S K Chemicals
7.14.1 S K Chemicals Corporate Summary
7.14.2 S K Chemicals Business Overview
7.14.3 S K Chemicals Preventable Vaccines Major Product Offerings
7.14.4 S K Chemicals Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.14.5 S K Chemicals Key News
7.15 Shenzhen Kangtai Biological Products
7.15.1 Shenzhen Kangtai Biological Products Corporate Summary
7.15.2 Shenzhen Kangtai Biological Products Business Overview
7.15.3 Shenzhen Kangtai Biological Products Preventable Vaccines Major Product Offerings
7.15.4 Shenzhen Kangtai Biological Products Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.15.5 Shenzhen Kangtai Biological Products Key News
7.16 Sinovac Biotech
7.16.1 Sinovac Biotech Corporate Summary
7.16.2 Sinovac Biotech Business Overview
7.16.3 Sinovac Biotech Preventable Vaccines Major Product Offerings
7.16.4 Sinovac Biotech Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.16.5 Sinovac Biotech Key News
7.17 Janssen Pharmaceuticals
7.17.1 Janssen Pharmaceuticals Corporate Summary
7.17.2 Janssen Pharmaceuticals Business Overview
7.17.3 Janssen Pharmaceuticals Preventable Vaccines Major Product Offerings
7.17.4 Janssen Pharmaceuticals Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.17.5 Janssen Pharmaceuticals Key News
7.18 Crucell
7.18.1 Crucell Corporate Summary
7.18.2 Crucell Business Overview
7.18.3 Crucell Preventable Vaccines Major Product Offerings
7.18.4 Crucell Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.18.5 Crucell Key News
7.19 Bavarian Nordic
7.19.1 Bavarian Nordic Corporate Summary
7.19.2 Bavarian Nordic Business Overview
7.19.3 Bavarian Nordic Preventable Vaccines Major Product Offerings
7.19.4 Bavarian Nordic Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.19.5 Bavarian Nordic Key News
7.20 Baxter
7.20.1 Baxter Corporate Summary
7.20.2 Baxter Business Overview
7.20.3 Baxter Preventable Vaccines Major Product Offerings
7.20.4 Baxter Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.20.5 Baxter Key News
7.21 Bharat Biotech
7.21.1 Bharat Biotech Corporate Summary
7.21.2 Bharat Biotech Business Overview
7.21.3 Bharat Biotech Preventable Vaccines Major Product Offerings
7.21.4 Bharat Biotech Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.21.5 Bharat Biotech Key News
7.22 Dynavax
7.22.1 Dynavax Corporate Summary
7.22.2 Dynavax Business Overview
7.22.3 Dynavax Preventable Vaccines Major Product Offerings
7.22.4 Dynavax Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.22.5 Dynavax Key News
7.23 Bausch Health
7.23.1 Bausch Health Corporate Summary
7.23.2 Bausch Health Business Overview
7.23.3 Bausch Health Preventable Vaccines Major Product Offerings
7.23.4 Bausch Health Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.23.5 Bausch Health Key News
7.24 Protein Sciences
7.24.1 Protein Sciences Corporate Summary
7.24.2 Protein Sciences Business Overview
7.24.3 Protein Sciences Preventable Vaccines Major Product Offerings
7.24.4 Protein Sciences Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.24.5 Protein Sciences Key News
7.25 Panacea Biotec
7.25.1 Panacea Biotec Corporate Summary
7.25.2 Panacea Biotec Business Overview
7.25.3 Panacea Biotec Preventable Vaccines Major Product Offerings
7.25.4 Panacea Biotec Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.25.5 Panacea Biotec Key News
8 GLOBAL PREVENTABLE VACCINES PRODUCTION CAPACITY, ANALYSIS
8.1 Global Preventable Vaccines Production Capacity, 2017-2028
8.2 Preventable Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Preventable Vaccines Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 PREVENTABLE VACCINES SUPPLY CHAIN ANALYSIS
10.1 Preventable Vaccines Industry Value Chain
10.2 Preventable Vaccines Upstream Market
10.3 Preventable Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Preventable Vaccines Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Preventable Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Preventable Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL PREVENTABLE VACCINES OVERALL MARKET SIZE
2.1 Global Preventable Vaccines Market Size: 2021 VS 2028
2.2 Global Preventable Vaccines Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Preventable Vaccines Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Preventable Vaccines Players in Global Market
3.2 Top Global Preventable Vaccines Companies Ranked by Revenue
3.3 Global Preventable Vaccines Revenue by Companies
3.4 Global Preventable Vaccines Sales by Companies
3.5 Global Preventable Vaccines Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Preventable Vaccines Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Preventable Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Preventable Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Preventable Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Preventable Vaccines Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Preventable Vaccines Market Size Markets, 2021 & 2028
4.1.2 Adult Preventable Vaccines
4.1.3 Pediatric Preventable Vaccines
4.2 By Type - Global Preventable Vaccines Revenue & Forecasts
4.2.1 By Type - Global Preventable Vaccines Revenue, 2017-2022
4.2.2 By Type - Global Preventable Vaccines Revenue, 2023-2028
4.2.3 By Type - Global Preventable Vaccines Revenue Market Share, 2017-2028
4.3 By Type - Global Preventable Vaccines Sales & Forecasts
4.3.1 By Type - Global Preventable Vaccines Sales, 2017-2022
4.3.2 By Type - Global Preventable Vaccines Sales, 2023-2028
4.3.3 By Type - Global Preventable Vaccines Sales Market Share, 2017-2028
4.4 By Type - Global Preventable Vaccines Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Preventable Vaccines Market Size, 2021 & 2028
5.1.2 Bacterial Diseases
5.1.3 Virus Diseases
5.2 By Application - Global Preventable Vaccines Revenue & Forecasts
5.2.1 By Application - Global Preventable Vaccines Revenue, 2017-2022
5.2.2 By Application - Global Preventable Vaccines Revenue, 2023-2028
5.2.3 By Application - Global Preventable Vaccines Revenue Market Share, 2017-2028
5.3 By Application - Global Preventable Vaccines Sales & Forecasts
5.3.1 By Application - Global Preventable Vaccines Sales, 2017-2022
5.3.2 By Application - Global Preventable Vaccines Sales, 2023-2028
5.3.3 By Application - Global Preventable Vaccines Sales Market Share, 2017-2028
5.4 By Application - Global Preventable Vaccines Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Preventable Vaccines Market Size, 2021 & 2028
6.2 By Region - Global Preventable Vaccines Revenue & Forecasts
6.2.1 By Region - Global Preventable Vaccines Revenue, 2017-2022
6.2.2 By Region - Global Preventable Vaccines Revenue, 2023-2028
6.2.3 By Region - Global Preventable Vaccines Revenue Market Share, 2017-2028
6.3 By Region - Global Preventable Vaccines Sales & Forecasts
6.3.1 By Region - Global Preventable Vaccines Sales, 2017-2022
6.3.2 By Region - Global Preventable Vaccines Sales, 2023-2028
6.3.3 By Region - Global Preventable Vaccines Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Preventable Vaccines Revenue, 2017-2028
6.4.2 By Country - North America Preventable Vaccines Sales, 2017-2028
6.4.3 US Preventable Vaccines Market Size, 2017-2028
6.4.4 Canada Preventable Vaccines Market Size, 2017-2028
6.4.5 Mexico Preventable Vaccines Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Preventable Vaccines Revenue, 2017-2028
6.5.2 By Country - Europe Preventable Vaccines Sales, 2017-2028
6.5.3 Germany Preventable Vaccines Market Size, 2017-2028
6.5.4 France Preventable Vaccines Market Size, 2017-2028
6.5.5 U.K. Preventable Vaccines Market Size, 2017-2028
6.5.6 Italy Preventable Vaccines Market Size, 2017-2028
6.5.7 Russia Preventable Vaccines Market Size, 2017-2028
6.5.8 Nordic Countries Preventable Vaccines Market Size, 2017-2028
6.5.9 Benelux Preventable Vaccines Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Preventable Vaccines Revenue, 2017-2028
6.6.2 By Region - Asia Preventable Vaccines Sales, 2017-2028
6.6.3 China Preventable Vaccines Market Size, 2017-2028
6.6.4 Japan Preventable Vaccines Market Size, 2017-2028
6.6.5 South Korea Preventable Vaccines Market Size, 2017-2028
6.6.6 Southeast Asia Preventable Vaccines Market Size, 2017-2028
6.6.7 India Preventable Vaccines Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Preventable Vaccines Revenue, 2017-2028
6.7.2 By Country - South America Preventable Vaccines Sales, 2017-2028
6.7.3 Brazil Preventable Vaccines Market Size, 2017-2028
6.7.4 Argentina Preventable Vaccines Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Preventable Vaccines Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Preventable Vaccines Sales, 2017-2028
6.8.3 Turkey Preventable Vaccines Market Size, 2017-2028
6.8.4 Israel Preventable Vaccines Market Size, 2017-2028
6.8.5 Saudi Arabia Preventable Vaccines Market Size, 2017-2028
6.8.6 UAE Preventable Vaccines Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Corporate Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Preventable Vaccines Major Product Offerings
7.1.4 GlaxoSmithKline Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.1.5 GlaxoSmithKline Key News
7.2 Merck
7.2.1 Merck Corporate Summary
7.2.2 Merck Business Overview
7.2.3 Merck Preventable Vaccines Major Product Offerings
7.2.4 Merck Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.2.5 Merck Key News
7.3 Novartis
7.3.1 Novartis Corporate Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Preventable Vaccines Major Product Offerings
7.3.4 Novartis Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.3.5 Novartis Key News
7.4 Pfizer
7.4.1 Pfizer Corporate Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Preventable Vaccines Major Product Offerings
7.4.4 Pfizer Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.4.5 Pfizer Key News
7.5 Sanofi
7.5.1 Sanofi Corporate Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Preventable Vaccines Major Product Offerings
7.5.4 Sanofi Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.5.5 Sanofi Key News
7.6 Takeda Pharmaceutical
7.6.1 Takeda Pharmaceutical Corporate Summary
7.6.2 Takeda Pharmaceutical Business Overview
7.6.3 Takeda Pharmaceutical Preventable Vaccines Major Product Offerings
7.6.4 Takeda Pharmaceutical Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.6.5 Takeda Pharmaceutical Key News
7.7 Abbott
7.7.1 Abbott Corporate Summary
7.7.2 Abbott Business Overview
7.7.3 Abbott Preventable Vaccines Major Product Offerings
7.7.4 Abbott Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.7.5 Abbott Key News
7.8 Roche
7.8.1 Roche Corporate Summary
7.8.2 Roche Business Overview
7.8.3 Roche Preventable Vaccines Major Product Offerings
7.8.4 Roche Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.8.5 Roche Key News
7.9 AstraZeneca
7.9.1 AstraZeneca Corporate Summary
7.9.2 AstraZeneca Business Overview
7.9.3 AstraZeneca Preventable Vaccines Major Product Offerings
7.9.4 AstraZeneca Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.9.5 AstraZeneca Key News
7.10 Mitsubishi Tanabe Pharma
7.10.1 Mitsubishi Tanabe Pharma Corporate Summary
7.10.2 Mitsubishi Tanabe Pharma Business Overview
7.10.3 Mitsubishi Tanabe Pharma Preventable Vaccines Major Product Offerings
7.10.4 Mitsubishi Tanabe Pharma Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.10.5 Mitsubishi Tanabe Pharma Key News
7.11 Lupin
7.11.1 Lupin Corporate Summary
7.11.2 Lupin Preventable Vaccines Business Overview
7.11.3 Lupin Preventable Vaccines Major Product Offerings
7.11.4 Lupin Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.11.5 Lupin Key News
7.12 Serum Institute of India
7.12.1 Serum Institute of India Corporate Summary
7.12.2 Serum Institute of India Preventable Vaccines Business Overview
7.12.3 Serum Institute of India Preventable Vaccines Major Product Offerings
7.12.4 Serum Institute of India Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.12.5 Serum Institute of India Key News
7.13 LG Life Sciences
7.13.1 LG Life Sciences Corporate Summary
7.13.2 LG Life Sciences Preventable Vaccines Business Overview
7.13.3 LG Life Sciences Preventable Vaccines Major Product Offerings
7.13.4 LG Life Sciences Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.13.5 LG Life Sciences Key News
7.14 S K Chemicals
7.14.1 S K Chemicals Corporate Summary
7.14.2 S K Chemicals Business Overview
7.14.3 S K Chemicals Preventable Vaccines Major Product Offerings
7.14.4 S K Chemicals Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.14.5 S K Chemicals Key News
7.15 Shenzhen Kangtai Biological Products
7.15.1 Shenzhen Kangtai Biological Products Corporate Summary
7.15.2 Shenzhen Kangtai Biological Products Business Overview
7.15.3 Shenzhen Kangtai Biological Products Preventable Vaccines Major Product Offerings
7.15.4 Shenzhen Kangtai Biological Products Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.15.5 Shenzhen Kangtai Biological Products Key News
7.16 Sinovac Biotech
7.16.1 Sinovac Biotech Corporate Summary
7.16.2 Sinovac Biotech Business Overview
7.16.3 Sinovac Biotech Preventable Vaccines Major Product Offerings
7.16.4 Sinovac Biotech Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.16.5 Sinovac Biotech Key News
7.17 Janssen Pharmaceuticals
7.17.1 Janssen Pharmaceuticals Corporate Summary
7.17.2 Janssen Pharmaceuticals Business Overview
7.17.3 Janssen Pharmaceuticals Preventable Vaccines Major Product Offerings
7.17.4 Janssen Pharmaceuticals Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.17.5 Janssen Pharmaceuticals Key News
7.18 Crucell
7.18.1 Crucell Corporate Summary
7.18.2 Crucell Business Overview
7.18.3 Crucell Preventable Vaccines Major Product Offerings
7.18.4 Crucell Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.18.5 Crucell Key News
7.19 Bavarian Nordic
7.19.1 Bavarian Nordic Corporate Summary
7.19.2 Bavarian Nordic Business Overview
7.19.3 Bavarian Nordic Preventable Vaccines Major Product Offerings
7.19.4 Bavarian Nordic Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.19.5 Bavarian Nordic Key News
7.20 Baxter
7.20.1 Baxter Corporate Summary
7.20.2 Baxter Business Overview
7.20.3 Baxter Preventable Vaccines Major Product Offerings
7.20.4 Baxter Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.20.5 Baxter Key News
7.21 Bharat Biotech
7.21.1 Bharat Biotech Corporate Summary
7.21.2 Bharat Biotech Business Overview
7.21.3 Bharat Biotech Preventable Vaccines Major Product Offerings
7.21.4 Bharat Biotech Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.21.5 Bharat Biotech Key News
7.22 Dynavax
7.22.1 Dynavax Corporate Summary
7.22.2 Dynavax Business Overview
7.22.3 Dynavax Preventable Vaccines Major Product Offerings
7.22.4 Dynavax Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.22.5 Dynavax Key News
7.23 Bausch Health
7.23.1 Bausch Health Corporate Summary
7.23.2 Bausch Health Business Overview
7.23.3 Bausch Health Preventable Vaccines Major Product Offerings
7.23.4 Bausch Health Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.23.5 Bausch Health Key News
7.24 Protein Sciences
7.24.1 Protein Sciences Corporate Summary
7.24.2 Protein Sciences Business Overview
7.24.3 Protein Sciences Preventable Vaccines Major Product Offerings
7.24.4 Protein Sciences Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.24.5 Protein Sciences Key News
7.25 Panacea Biotec
7.25.1 Panacea Biotec Corporate Summary
7.25.2 Panacea Biotec Business Overview
7.25.3 Panacea Biotec Preventable Vaccines Major Product Offerings
7.25.4 Panacea Biotec Preventable Vaccines Sales and Revenue in Global (2017-2022)
7.25.5 Panacea Biotec Key News
8 GLOBAL PREVENTABLE VACCINES PRODUCTION CAPACITY, ANALYSIS
8.1 Global Preventable Vaccines Production Capacity, 2017-2028
8.2 Preventable Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Preventable Vaccines Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 PREVENTABLE VACCINES SUPPLY CHAIN ANALYSIS
10.1 Preventable Vaccines Industry Value Chain
10.2 Preventable Vaccines Upstream Market
10.3 Preventable Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Preventable Vaccines Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Preventable Vaccines in Global Market
Table 2. Top Preventable Vaccines Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Preventable Vaccines Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Preventable Vaccines Revenue Share by Companies, 2017-2022
Table 5. Global Preventable Vaccines Sales by Companies, (K Units), 2017-2022
Table 6. Global Preventable Vaccines Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Preventable Vaccines Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Preventable Vaccines Product Type
Table 9. List of Global Tier 1 Preventable Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Preventable Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Preventable Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Preventable Vaccines Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Preventable Vaccines Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Preventable Vaccines Sales (K Units), 2017-2022
Table 15. By Type - Global Preventable Vaccines Sales (K Units), 2023-2028
Table 16. By Application – Global Preventable Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Preventable Vaccines Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Preventable Vaccines Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Preventable Vaccines Sales (K Units), 2017-2022
Table 20. By Application - Global Preventable Vaccines Sales (K Units), 2023-2028
Table 21. By Region – Global Preventable Vaccines Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Preventable Vaccines Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Preventable Vaccines Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Preventable Vaccines Sales (K Units), 2017-2022
Table 25. By Region - Global Preventable Vaccines Sales (K Units), 2023-2028
Table 26. By Country - North America Preventable Vaccines Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Preventable Vaccines Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Preventable Vaccines Sales, (K Units), 2017-2022
Table 29. By Country - North America Preventable Vaccines Sales, (K Units), 2023-2028
Table 30. By Country - Europe Preventable Vaccines Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Preventable Vaccines Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Preventable Vaccines Sales, (K Units), 2017-2022
Table 33. By Country - Europe Preventable Vaccines Sales, (K Units), 2023-2028
Table 34. By Region - Asia Preventable Vaccines Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Preventable Vaccines Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Preventable Vaccines Sales, (K Units), 2017-2022
Table 37. By Region - Asia Preventable Vaccines Sales, (K Units), 2023-2028
Table 38. By Country - South America Preventable Vaccines Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Preventable Vaccines Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Preventable Vaccines Sales, (K Units), 2017-2022
Table 41. By Country - South America Preventable Vaccines Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Preventable Vaccines Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Preventable Vaccines Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Preventable Vaccines Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Preventable Vaccines Sales, (K Units), 2023-2028
Table 46. GlaxoSmithKline Corporate Summary
Table 47. GlaxoSmithKline Preventable Vaccines Product Offerings
Table 48. GlaxoSmithKline Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Merck Corporate Summary
Table 50. Merck Preventable Vaccines Product Offerings
Table 51. Merck Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Novartis Corporate Summary
Table 53. Novartis Preventable Vaccines Product Offerings
Table 54. Novartis Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Pfizer Corporate Summary
Table 56. Pfizer Preventable Vaccines Product Offerings
Table 57. Pfizer Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Sanofi Corporate Summary
Table 59. Sanofi Preventable Vaccines Product Offerings
Table 60. Sanofi Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Takeda Pharmaceutical Corporate Summary
Table 62. Takeda Pharmaceutical Preventable Vaccines Product Offerings
Table 63. Takeda Pharmaceutical Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Abbott Corporate Summary
Table 65. Abbott Preventable Vaccines Product Offerings
Table 66. Abbott Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Roche Corporate Summary
Table 68. Roche Preventable Vaccines Product Offerings
Table 69. Roche Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. AstraZeneca Corporate Summary
Table 71. AstraZeneca Preventable Vaccines Product Offerings
Table 72. AstraZeneca Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Mitsubishi Tanabe Pharma Corporate Summary
Table 74. Mitsubishi Tanabe Pharma Preventable Vaccines Product Offerings
Table 75. Mitsubishi Tanabe Pharma Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Lupin Corporate Summary
Table 77. Lupin Preventable Vaccines Product Offerings
Table 78. Lupin Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. Serum Institute of India Corporate Summary
Table 80. Serum Institute of India Preventable Vaccines Product Offerings
Table 81. Serum Institute of India Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 82. LG Life Sciences Corporate Summary
Table 83. LG Life Sciences Preventable Vaccines Product Offerings
Table 84. LG Life Sciences Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 85. S K Chemicals Corporate Summary
Table 86. S K Chemicals Preventable Vaccines Product Offerings
Table 87. S K Chemicals Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 88. Shenzhen Kangtai Biological Products Corporate Summary
Table 89. Shenzhen Kangtai Biological Products Preventable Vaccines Product Offerings
Table 90. Shenzhen Kangtai Biological Products Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 91. Sinovac Biotech Corporate Summary
Table 92. Sinovac Biotech Preventable Vaccines Product Offerings
Table 93. Sinovac Biotech Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 94. Janssen Pharmaceuticals Corporate Summary
Table 95. Janssen Pharmaceuticals Preventable Vaccines Product Offerings
Table 96. Janssen Pharmaceuticals Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 97. Crucell Corporate Summary
Table 98. Crucell Preventable Vaccines Product Offerings
Table 99. Crucell Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 100. Bavarian Nordic Corporate Summary
Table 101. Bavarian Nordic Preventable Vaccines Product Offerings
Table 102. Bavarian Nordic Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 103. Baxter Corporate Summary
Table 104. Baxter Preventable Vaccines Product Offerings
Table 105. Baxter Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 106. Bharat Biotech Corporate Summary
Table 107. Bharat Biotech Preventable Vaccines Product Offerings
Table 108. Bharat Biotech Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 109. Dynavax Corporate Summary
Table 110. Dynavax Preventable Vaccines Product Offerings
Table 111. Dynavax Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 112. Bausch Health Corporate Summary
Table 113. Bausch Health Preventable Vaccines Product Offerings
Table 114. Bausch Health Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 115. Protein Sciences Corporate Summary
Table 116. Protein Sciences Preventable Vaccines Product Offerings
Table 117. Protein Sciences Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 118. Panacea Biotec Corporate Summary
Table 119. Panacea Biotec Preventable Vaccines Product Offerings
Table 120. Panacea Biotec Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 121. Preventable Vaccines Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 122. Global Preventable Vaccines Capacity Market Share of Key Manufacturers, 2020-2022
Table 123. Global Preventable Vaccines Production by Region, 2017-2022 (K Units)
Table 124. Global Preventable Vaccines Production by Region, 2023-2028 (K Units)
Table 125. Preventable Vaccines Market Opportunities & Trends in Global Market
Table 126. Preventable Vaccines Market Drivers in Global Market
Table 127. Preventable Vaccines Market Restraints in Global Market
Table 128. Preventable Vaccines Raw Materials
Table 129. Preventable Vaccines Raw Materials Suppliers in Global Market
Table 130. Typical Preventable Vaccines Downstream
Table 131. Preventable Vaccines Downstream Clients in Global Market
Table 132. Preventable Vaccines Distributors and Sales Agents in Global Market
Table 1. Key Players of Preventable Vaccines in Global Market
Table 2. Top Preventable Vaccines Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Preventable Vaccines Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Preventable Vaccines Revenue Share by Companies, 2017-2022
Table 5. Global Preventable Vaccines Sales by Companies, (K Units), 2017-2022
Table 6. Global Preventable Vaccines Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Preventable Vaccines Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Preventable Vaccines Product Type
Table 9. List of Global Tier 1 Preventable Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Preventable Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Preventable Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Preventable Vaccines Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Preventable Vaccines Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Preventable Vaccines Sales (K Units), 2017-2022
Table 15. By Type - Global Preventable Vaccines Sales (K Units), 2023-2028
Table 16. By Application – Global Preventable Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Preventable Vaccines Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Preventable Vaccines Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Preventable Vaccines Sales (K Units), 2017-2022
Table 20. By Application - Global Preventable Vaccines Sales (K Units), 2023-2028
Table 21. By Region – Global Preventable Vaccines Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Preventable Vaccines Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Preventable Vaccines Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Preventable Vaccines Sales (K Units), 2017-2022
Table 25. By Region - Global Preventable Vaccines Sales (K Units), 2023-2028
Table 26. By Country - North America Preventable Vaccines Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Preventable Vaccines Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Preventable Vaccines Sales, (K Units), 2017-2022
Table 29. By Country - North America Preventable Vaccines Sales, (K Units), 2023-2028
Table 30. By Country - Europe Preventable Vaccines Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Preventable Vaccines Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Preventable Vaccines Sales, (K Units), 2017-2022
Table 33. By Country - Europe Preventable Vaccines Sales, (K Units), 2023-2028
Table 34. By Region - Asia Preventable Vaccines Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Preventable Vaccines Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Preventable Vaccines Sales, (K Units), 2017-2022
Table 37. By Region - Asia Preventable Vaccines Sales, (K Units), 2023-2028
Table 38. By Country - South America Preventable Vaccines Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Preventable Vaccines Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Preventable Vaccines Sales, (K Units), 2017-2022
Table 41. By Country - South America Preventable Vaccines Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Preventable Vaccines Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Preventable Vaccines Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Preventable Vaccines Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Preventable Vaccines Sales, (K Units), 2023-2028
Table 46. GlaxoSmithKline Corporate Summary
Table 47. GlaxoSmithKline Preventable Vaccines Product Offerings
Table 48. GlaxoSmithKline Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Merck Corporate Summary
Table 50. Merck Preventable Vaccines Product Offerings
Table 51. Merck Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Novartis Corporate Summary
Table 53. Novartis Preventable Vaccines Product Offerings
Table 54. Novartis Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Pfizer Corporate Summary
Table 56. Pfizer Preventable Vaccines Product Offerings
Table 57. Pfizer Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Sanofi Corporate Summary
Table 59. Sanofi Preventable Vaccines Product Offerings
Table 60. Sanofi Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Takeda Pharmaceutical Corporate Summary
Table 62. Takeda Pharmaceutical Preventable Vaccines Product Offerings
Table 63. Takeda Pharmaceutical Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Abbott Corporate Summary
Table 65. Abbott Preventable Vaccines Product Offerings
Table 66. Abbott Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Roche Corporate Summary
Table 68. Roche Preventable Vaccines Product Offerings
Table 69. Roche Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. AstraZeneca Corporate Summary
Table 71. AstraZeneca Preventable Vaccines Product Offerings
Table 72. AstraZeneca Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Mitsubishi Tanabe Pharma Corporate Summary
Table 74. Mitsubishi Tanabe Pharma Preventable Vaccines Product Offerings
Table 75. Mitsubishi Tanabe Pharma Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Lupin Corporate Summary
Table 77. Lupin Preventable Vaccines Product Offerings
Table 78. Lupin Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. Serum Institute of India Corporate Summary
Table 80. Serum Institute of India Preventable Vaccines Product Offerings
Table 81. Serum Institute of India Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 82. LG Life Sciences Corporate Summary
Table 83. LG Life Sciences Preventable Vaccines Product Offerings
Table 84. LG Life Sciences Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 85. S K Chemicals Corporate Summary
Table 86. S K Chemicals Preventable Vaccines Product Offerings
Table 87. S K Chemicals Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 88. Shenzhen Kangtai Biological Products Corporate Summary
Table 89. Shenzhen Kangtai Biological Products Preventable Vaccines Product Offerings
Table 90. Shenzhen Kangtai Biological Products Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 91. Sinovac Biotech Corporate Summary
Table 92. Sinovac Biotech Preventable Vaccines Product Offerings
Table 93. Sinovac Biotech Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 94. Janssen Pharmaceuticals Corporate Summary
Table 95. Janssen Pharmaceuticals Preventable Vaccines Product Offerings
Table 96. Janssen Pharmaceuticals Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 97. Crucell Corporate Summary
Table 98. Crucell Preventable Vaccines Product Offerings
Table 99. Crucell Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 100. Bavarian Nordic Corporate Summary
Table 101. Bavarian Nordic Preventable Vaccines Product Offerings
Table 102. Bavarian Nordic Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 103. Baxter Corporate Summary
Table 104. Baxter Preventable Vaccines Product Offerings
Table 105. Baxter Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 106. Bharat Biotech Corporate Summary
Table 107. Bharat Biotech Preventable Vaccines Product Offerings
Table 108. Bharat Biotech Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 109. Dynavax Corporate Summary
Table 110. Dynavax Preventable Vaccines Product Offerings
Table 111. Dynavax Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 112. Bausch Health Corporate Summary
Table 113. Bausch Health Preventable Vaccines Product Offerings
Table 114. Bausch Health Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 115. Protein Sciences Corporate Summary
Table 116. Protein Sciences Preventable Vaccines Product Offerings
Table 117. Protein Sciences Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 118. Panacea Biotec Corporate Summary
Table 119. Panacea Biotec Preventable Vaccines Product Offerings
Table 120. Panacea Biotec Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 121. Preventable Vaccines Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 122. Global Preventable Vaccines Capacity Market Share of Key Manufacturers, 2020-2022
Table 123. Global Preventable Vaccines Production by Region, 2017-2022 (K Units)
Table 124. Global Preventable Vaccines Production by Region, 2023-2028 (K Units)
Table 125. Preventable Vaccines Market Opportunities & Trends in Global Market
Table 126. Preventable Vaccines Market Drivers in Global Market
Table 127. Preventable Vaccines Market Restraints in Global Market
Table 128. Preventable Vaccines Raw Materials
Table 129. Preventable Vaccines Raw Materials Suppliers in Global Market
Table 130. Typical Preventable Vaccines Downstream
Table 131. Preventable Vaccines Downstream Clients in Global Market
Table 132. Preventable Vaccines Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Preventable Vaccines Segment by Type
Figure 2. Preventable Vaccines Segment by Application
Figure 3. Global Preventable Vaccines Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Preventable Vaccines Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Preventable Vaccines Revenue, 2017-2028 (US$, Mn)
Figure 7. Preventable Vaccines Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Preventable Vaccines Revenue in 2021
Figure 9. By Type - Global Preventable Vaccines Sales Market Share, 2017-2028
Figure 10. By Type - Global Preventable Vaccines Revenue Market Share, 2017-2028
Figure 11. By Type - Global Preventable Vaccines Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Preventable Vaccines Sales Market Share, 2017-2028
Figure 13. By Application - Global Preventable Vaccines Revenue Market Share, 2017-2028
Figure 14. By Application - Global Preventable Vaccines Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Preventable Vaccines Sales Market Share, 2017-2028
Figure 16. By Region - Global Preventable Vaccines Revenue Market Share, 2017-2028
Figure 17. By Country - North America Preventable Vaccines Revenue Market Share, 2017-2028
Figure 18. By Country - North America Preventable Vaccines Sales Market Share, 2017-2028
Figure 19. US Preventable Vaccines Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Preventable Vaccines Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Preventable Vaccines Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Preventable Vaccines Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Preventable Vaccines Sales Market Share, 2017-2028
Figure 24. Germany Preventable Vaccines Revenue, (US$, Mn), 2017-2028
Figure 25. France Preventable Vaccines Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Preventable Vaccines Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Preventable Vaccines Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Preventable Vaccines Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Preventable Vaccines Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Preventable Vaccines Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Preventable Vaccines Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Preventable Vaccines Sales Market Share, 2017-2028
Figure 33. China Preventable Vaccines Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Preventable Vaccines Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Preventable Vaccines Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Preventable Vaccines Revenue, (US$, Mn), 2017-2028
Figure 37. India Preventable Vaccines Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Preventable Vaccines Revenue Market Share, 2017-2028
Figure 39. By Country - South America Preventable Vaccines Sales Market Share, 2017-2028
Figure 40. Brazil Preventable Vaccines Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Preventable Vaccines Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Preventable Vaccines Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Preventable Vaccines Sales Market Share, 2017-2028
Figure 44. Turkey Preventable Vaccines Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Preventable Vaccines Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Preventable Vaccines Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Preventable Vaccines Revenue, (US$, Mn), 2017-2028
Figure 48. Global Preventable Vaccines Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Preventable Vaccines by Region, 2021 VS 2028
Figure 50. Preventable Vaccines Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Preventable Vaccines Segment by Type
Figure 2. Preventable Vaccines Segment by Application
Figure 3. Global Preventable Vaccines Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Preventable Vaccines Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Preventable Vaccines Revenue, 2017-2028 (US$, Mn)
Figure 7. Preventable Vaccines Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Preventable Vaccines Revenue in 2021
Figure 9. By Type - Global Preventable Vaccines Sales Market Share, 2017-2028
Figure 10. By Type - Global Preventable Vaccines Revenue Market Share, 2017-2028
Figure 11. By Type - Global Preventable Vaccines Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Preventable Vaccines Sales Market Share, 2017-2028
Figure 13. By Application - Global Preventable Vaccines Revenue Market Share, 2017-2028
Figure 14. By Application - Global Preventable Vaccines Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Preventable Vaccines Sales Market Share, 2017-2028
Figure 16. By Region - Global Preventable Vaccines Revenue Market Share, 2017-2028
Figure 17. By Country - North America Preventable Vaccines Revenue Market Share, 2017-2028
Figure 18. By Country - North America Preventable Vaccines Sales Market Share, 2017-2028
Figure 19. US Preventable Vaccines Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Preventable Vaccines Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Preventable Vaccines Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Preventable Vaccines Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Preventable Vaccines Sales Market Share, 2017-2028
Figure 24. Germany Preventable Vaccines Revenue, (US$, Mn), 2017-2028
Figure 25. France Preventable Vaccines Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Preventable Vaccines Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Preventable Vaccines Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Preventable Vaccines Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Preventable Vaccines Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Preventable Vaccines Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Preventable Vaccines Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Preventable Vaccines Sales Market Share, 2017-2028
Figure 33. China Preventable Vaccines Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Preventable Vaccines Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Preventable Vaccines Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Preventable Vaccines Revenue, (US$, Mn), 2017-2028
Figure 37. India Preventable Vaccines Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Preventable Vaccines Revenue Market Share, 2017-2028
Figure 39. By Country - South America Preventable Vaccines Sales Market Share, 2017-2028
Figure 40. Brazil Preventable Vaccines Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Preventable Vaccines Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Preventable Vaccines Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Preventable Vaccines Sales Market Share, 2017-2028
Figure 44. Turkey Preventable Vaccines Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Preventable Vaccines Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Preventable Vaccines Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Preventable Vaccines Revenue, (US$, Mn), 2017-2028
Figure 48. Global Preventable Vaccines Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Preventable Vaccines by Region, 2021 VS 2028
Figure 50. Preventable Vaccines Industry Value Chain
Figure 51. Marketing Channels
